Das Produkt wurde korrekt in den Warenkorb gelegt.

discount label
H-SIYRYYGL-OH
3D-Ansicht

Biosynth logo

H-SIYRYYGL-OH

Ref. 3D-PP46914

1mg
202,00 €
10mg
234,00 €
100mg
412,00 €
Voraussichtliche Lieferung in Vereinigte Staaten, am Freitag 27. Dezember 2024

Produktinformation

Name:
H-SIYRYYGL-OH
Synonyme:
  • NH2-Ser-Ile-Tyr-Arg-Tyr-Tyr-Gly-Leu-OH
Beschreibung:

Peptide H-SIYRYYGL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SIYRYYGL-OH include the following: Endogenous viral antigen processing generates peptide-specific MHC class I cell-surface clusters X Lu, JS Gibbs, HD Hickman , A David - Proceedings of the , 2012 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1208696109 EXPLORING THE EMERGING ROLES OF T CELLS IN CANCER AND INFECTIOUS DISEASE W Chaisawangwong - 2022 - jscholarship.library.jhu.eduhttps://jscholarship.library.jhu.edu/bitstream/1774.2/67574/1/CHAISAWANGWONG-DISSERTATION-2022.pdf Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins TB Fessenden , LE Stopfer , F Chatterjee - for ImmunoTherapy of , 2022 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277371/ Antigen-specific blockade of T cells in vivo using dimeric MHC peptide SM O'Herrin, JE Slansky, Q Tang - The Journal of , 2001 - journals.aai.orghttps://journals.aai.org/jimmunol/article/167/5/2555/34461 A yeast display system for engineering functional peptide-MHC complexes SE Brophy, PD Holler, DM Kranz - Journal of immunological methods, 2003 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022175902004398 Cellular uptake followed by class I MHC presentation of some exogenous peptides contributes to T cell stimulatory capacity SE Brophy, LL Jones , PD Holler, DM Kranz - Molecular immunology, 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0161589006006924 Combinatorial peptide library methods for immunobiology research R Liu, AM Enstrom, KS Lam - Experimental hematology, 2003 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0301472X02010081 Molecular basis for the recognition of two structurally different major histocompatibility complex/peptide complexes by a single T-cell receptor R Brock, KH Wiesmuller, G Jung - Proceedings of the , 1996 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.93.23.13108 Different strategies adopted by Kb and Ld to generate T cell specificity directed against their respective bound peptides NA Bowerman, LA Colf, KC Garcia , DM Kranz - Journal of biological , 2009 - ASBMBhttps://www.jbc.org/article/S0021-9258(20)37846-7/abstract The use of high-affinity T cell receptors to study specificity in the 2C T cell system NA Bowerman - 2009 - search.proquest.comhttps://search.proquest.com/openview/eeb7b2b1d06d6e56d878f6150fe7e477/1?pq-origsite=gscholar&cbl=18750 IL-7 receptor expression levels do not identify CD8+ memory T lymphocyte precursors following peptide immunization MH Lacombe, MP Hardy , J Rooney - The Journal of , 2005 - journals.aai.orghttps://journals.aai.org/jimmunol/article/175/7/4400/37070 Multiple Vaccinations Induce Regulatory T Cells That Reduce Therapeutic Function of Effector T Cells; Partial Depletion of CD4 Cells Restores Therapeutic Efficacy MG LaCelle, SM Jensen, BA Fox - Journal of Immunotherapy, 2006 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2006/11000/Multiple_Vaccinations_Induce_Regulatory_T_Cells.13.aspx NMR study on the interaction between MHC class I protein and its antigen peptide M Nakagawa, K Chiba-Kamoshida, K Udaka - Biochemical and , 2000 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X00938440 Bispecific agents target endogenous murine T cells against human tumor xenografts LA Rund , BK Cho, TC Manning - journal of cancer, 1999 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1097-0215(19990924)83:1%3C141::AID-IJC24%3E3.0.CO;2-0 Targeting virus entry and membrane fusion through specific peptide/MHC complexes using a high-affinity T-cell receptor KW Peng, PD Holler, BA Orr , DM Kranz , SJ Russell - Gene therapy, 2004 - nature.comhttps://www.nature.com/articles/3302286 Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone. K Udaka, KH Wiesmuller, S Kienle, G Jung - Journal of immunology , 1996 - journals.aai.orghttps://journals.aai.org/jimmunol/article-abstract/157/2/670/29511 Adoptive Transfer of CD25-Depleted Polyclonal T Cells Into Lymphopenic Hosts Promotes Spontaneous Tumor Rejection JP Kline , I Brown, TF Gajewski - Journal of Immunotherapy, 2006 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2006/11000/Adoptive_Transfer_of_CD25_Depleted_Polyclonal_T.12.aspx Promiscuous binding of extracellular peptides to cell surface class I MHC protein HN Eisen, XH Hou , C Shen, K Wang - Proceedings of the , 2012 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1201586109 Epitope stability in single chain trimers of a major histocompatibility complex class I molecule DS Hangadoumbo - 2009 - search.proquest.comhttps://search.proquest.com/openview/c50413fb7b0eed288207aa71a6f02ee3/1?pq-origsite=gscholar&cbl=18750 Targeting tumor cells with bispecific antibodies and T cells DM Kranz , TC Manning, LA Rund , BK Cho - Journal of controlled , 1998 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365997002393 Peptide antigen priming of naive, but not memory, CD8 T cells requires a third signal that can be provided by IL-12 CS Schmidt, MF Mescher - The Journal of Immunology, 2002 - journals.aai.orghttps://journals.aai.org/jimmunol/article/168/11/5521/34221 Adjuvant effect of IL-12: conversion of peptide antigen administration from tolerizing to immunizing for CD8+ T cells in vivo CS Schmidt, MF Mescher - The Journal of Immunology, 1999 - journals.aai.orghttps://journals.aai.org/jimmunol/article/163/5/2561/32848 Interleukin-12 as an adjuvant and activation signal for CD8 positive T lymphocytes in vivo CS Schmidt - 2000 - search.proquest.comhttps://search.proquest.com/openview/4ad3509a171d793e3b01263b2fbc9121/1?pq-origsite=gscholar&cbl=18750&diss=y Adoptive cell therapy using primary T lymphocytes with genetically engineered T cell receptors against melanoma and glioma C Soto - 2013 - ideals.illinois.eduhttps://www.ideals.illinois.edu/items/42424 Rapid tolerization of virus-activated tumor-specific CD8+ T cells in prostate tumors of TRAMP mice A Bai, E Higham, HN Eisen - Proceedings of the , 2008 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.0805599105

Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:

Chemische Eigenschaften

MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:

Gefahrenhinweise

UN-Nummer:
EQ:
Klasse:
H-Sätze:
P-Sätze:
Flugverbot:
Gefahrenhinweis:
Verpackungsgruppe:
LQ:

Technische Anfrage zu: 3D-PP46914 H-SIYRYYGL-OH

Bitte verwenden Sie stattdessen den Warenkorb, um ein Angebot oder eine Bestellung anzufordern

Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.

* Obligatorische felder
Willkommen bei CymitQuimica!Wir verwenden Cookies, um Ihren Besuch zu verbessern. Wir schließen Werbung nicht ein.

Bitte beachten Sie unsere Cookie-Richtlinie  für weitere Details oder passen Sie Ihre Einstellungen unter “Konfigurieren” an.